| TISIDB: an integrated repository portal for tumor–immune system interactions B Ru, CN Wong, Y Tong, JY Zhong, SSW Zhong, WC Wu, KC Chu, ... Bioinformatics 35 (20), 4200-4202, 2019 | 1432 | 2019 |
| Immune-based therapies for hepatocellular carcinoma DJ Pinato, N Guerra, P Fessas, R Murphy, T Mineo, FA Mauri, ... Oncogene 39 (18), 3620-3637, 2020 | 184 | 2020 |
| C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism Y Zhang, Q Yan, L Gong, H Xu, B Liu, X Fang, D Yu, L Li, T Wei, Y Wang, ... Oncogene 40 (6), 1147-1161, 2021 | 54 | 2021 |
| Qualification of tumour mutational burden by targeted next‐generation sequencing as a biomarker in hepatocellular carcinoma CN Wong, P Fessas, K Dominy, FA Mauri, T Kaneko, PD Parcq, ... Liver International 41 (1), 192-203, 2021 | 36 | 2021 |
| A phase Ib study of pembrolizumab following trans-arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): PETAL DJ Pinato, T Cole, B Bengsch, P Tait, AA Sayed, F Abomeli, ... Annals of Oncology 30, v288, 2019 | 30 | 2019 |
| CR2Cancer: a database for chromatin regulators in human cancer B Ru, J Sun, Y Tong, CN Wong, A Chandra, ATS Tang, LKY Chow, ... Nucleic Acids Research 46 (D1), D918-D924, 2018 | 28 | 2018 |
| MICMIC: identification of DNA methylation of distal regulatory regions with causal effects on tumorigenesis Y Tong, J Sun, CF Wong, Q Kang, B Ru, CN Wong, AS Chan, SY Leung, ... Genome biology 19, 1-17, 2018 | 20 | 2018 |
| Phenotypic characteristics of the tumour microenvironment in primary and secondary hepatocellular carcinoma P Fessas, P Spina, RL Boldorini, M Pirisi, R Minisini, FA Mauri, F Simpson, ... Cancers 13 (9), 2137, 2021 | 14 | 2021 |
| Enhanced mitophagy driven by ADAR1-GLI1 editing supports the self-renewal of cancer stem cells in HCC J Luo, L Gong, Y Yang, Y Zhang, Q Liu, L Bai, X Fang, B Zhang, J Huang, ... Hepatology 79 (1), 61-78, 2024 | 6 | 2024 |
| Correction: C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism Y Zhang, Q Yan, L Gong, H Xu, B Liu, X Fang, D Yu, L Li, T Wei, Y Wang, ... Oncogene 40 (35), 5451-5453, 2021 | 2 | 2021 |
| Applicability of routine targeted next-generation sequencing to estimate tumor mutational burden (TMB) in patients treated with immune checkpoint inhibitor therapy DJ Pinato, H Urus, T Newsom-Davis, P Du Parcq, K Belessiotis, L Mapara, ... Journal of Immunotherapy 43 (2), 53-56, 2020 | 2 | 2020 |
| PPM1G enhances hepatocellular carcinoma stemness via interacting with YBX1 S Liu, X Fang, J Luo, J Huang, Y Yang, B Liu, J Huang, CN Wong, ... Cancer Research 83 (7_Supplement), 2445-2445, 2023 | | 2023 |
| FASN inhibition overcomes immune evasion by upregulating MHC-I in hepatocellular carcinoma J Huang, WY Tsang, X Fang, Y Zhang, J Luo, L Gong, B Zhang, CN Wong, ... Cancer Research 83 (7_Supplement), 4452-4452, 2023 | | 2023 |
| Identification and characterization of the role of KRT17 in the stemness regulation of hepatocellular carcinoma X Fang, S Liu, L Ban, J Huang, J Luo, L Gong, B Zhang, B Liu, J Huang, ... Cancer Research 83 (7_Supplement), 2441-2441, 2023 | | 2023 |
| SOX4 promotes tumor development and immune evasion via disruption of zinc homeostasis between nasopharyngeal carcinoma cells and T cells Y Yang, L Gong, J Luo, X Fang, J Huang, L Bai, Q Liu, B Liu, S Liu, ... Cancer Research 83 (7_Supplement), 4450-4450, 2023 | | 2023 |
| Single-cell RNA sequencing (scRNA-Seq) from mice model reveals metastatic and stemness signatures in esophageal squamous cell carcinoma (ESCC) CN Wong, Y Zhang, B Ru, HY Zhou, KY Lam, XY Guan Cancer Research 82 (12_Supplement), 5982-5982, 2022 | | 2022 |
| Single cell RNA sequencing uncovers high-plasticity cell state during tumor metastasis Y Zhang, CN Wong, L Gong, X Guan, B Ru, B Liu Cancer Research 82 (12_Supplement), 5981-5981, 2022 | | 2022 |
| C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism (vol 40, pg 1147, 2021) Y Zhang, Q Yan, L Gong, H Xu, B Liu, X Fang, D Yu, L Li, T Wei, Y Wang, ... ONCOGENE 40 (35), 5451-5453, 2021 | | 2021 |
| Optimisation and qualification of tumour mutational burden (TMB) by targeted next-generation sequencing (TNGS) as a clinically applicable biomarker in hepatocellular carcinoma … CN Wong, K Dominy, F Mauri, T Kaneko, P Du Parcq, J Khorasad, ... Journal of Hepatology 73, S374-S375, 2020 | | 2020 |
